Navigation Links
Chem Rx Corporation Postpones Conference Call to Review Full Year 2007 Financial Results
Date:3/31/2008

LONG BEACH, N.Y., March 31 /PRNewswire-FirstCall/ -- Chem Rx Corporation (OTC Bulletin Board: PMQC, PMQCU, PMQCW), a leading provider of institutional pharmacy services, announced today that it has postponed its conference call to review 2007 financial results and discuss 2008 outlook that was originally scheduled for April 1, 2008 at 8:30 a.m. ET. Additional details about the timing of the 2007 financial results press release and corresponding conference call will be forthcoming shortly.

About Chem Rx Corporation

Founded more than 40 years ago, Chem Rx Corporation is a leading provider of institutional pharmacy services in the New York City metropolitan area, as well as parts of New Jersey, upstate New York, and Pennsylvania. Chem Rx's client base includes skilled nursing facilities and a wide range of other long-term care facilities. Through its services, Chem Rx provides more than 65,000 institutional residents with prescription and non-prescription drugs, intravenous medications, durable medical equipment items and surgical supplies. Chem Rx's website address is http://www.chemrx.net.

Forward Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements that are not historical facts. Such forward-looking statements are based upon the current beliefs and expectations of Chem Rx's management and are subject to risks and uncertainties that could cause actual results to differ from the forward-looking statements. The following factors, among others, could cause actual results to differ from those set forth in the forward-looking statements: compliance with government regulations; changes in legislation or regulatory environments; requirements or changes adversely affecting the health care industry, including changes in Medicare reimbursement policies; flu
'/>"/>

SOURCE Chem Rx Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Genaera Corporation Announces 2007 Financial Results
2. Chem Rx Corporation Schedules Conference Call to Review Full Year 2007 Financial Results
3. Immunosyn Corporation Announces 2007 Results, Files 10KSB
4. Spectros Corporation Reports 2007 Year-Over-Year Sales Rise 36%
5. Lentigen Corporation Announces Exclusive Licensing Agreement With Case Western Reserve University to Develop Novel Stem-Cell Therapy for Brain Cancer
6. Oregon Health Care Quality Corporation Receives Important Designation from U.S. Department of Health and Human Services
7. Psychemedics Corporation Authorizes A 250,000 Share Stock Repurchase Program
8. Dr. Linda McAllister Joins Arbor Vita Corporation as Vice President of Diagnostics
9. Webcast Alert: Neogen Corporation Announces 3rd Quarter Results
10. USANAs CEO Myron W. Wentz, Ph.D. Has Been Elected to Serve on Immunosyn Corporations Board of Directors
11. Volcano Corporation Presentation at Cowen Healthcare Conference to be Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)...Newswire/ -- BioTrends Research Group, Inc.,releas...M) publication, a,syndicated report offering compr...ia and bone and mineral metabolism in Chronic Kidn... information from 182 US,Nephrologists -- data wer...ne 2008., In the renal anemia market, while the u...
(Date:7/25/2008)...X, CALGARY, July 25 / Resv...X:RVX) is pleased to announce effective,immediatel...irectors. On,the subject of her appointment Jan Gr...xciting opportunity for me. The Company has done a...linical trials. I expect the next,foreseeable futu...
(Date:7/25/2008)...swire-FirstCall/ -- Caraco Pharmaceutical,Laborato...first quarter of,Fiscal 2009, ended June 30, 2008,...or the corresponding period of Fiscal 2008. This r...er of Fiscal 2008. Pre-tax income grew,to $14.6 mi...ared to a,pre-tax income of $9.6 million during th...
(Date:7/25/2008)...25 /- REvolution Computing will,lead ...R product at the,upcoming BioC 2008 conference in ... REvolution Computing Director of Community, Dr. D... Training Manager, and Martin Morgan of,the Fred H...ting,s BioC lab,will introduce participants to the...
Breaking Biology Technology:BioTrends Releases Quarterly TreatmentTrends(TM): Nephrology Report Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism 2BioTrends Releases Quarterly TreatmentTrends(TM): Nephrology Report Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism 3Jan Gray Joins Resverlogix Board of Directors 2Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 2Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 3Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 4Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 5Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 6Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 7REvolution Computing Offers Hands-On Tutorial of NWS Parallel Computing Environment at BioC 2008 2
..., Jolanta Kolodziejek, MSc, and Professor ... Group, Institute of Virology, University of Veter...z 1, A 1210 Vienna, Austria , , ... template employed in sequencing PCR (cycle sequen...cleotide sequencing. The presence of , co...
..., Anne-Lise Brresen-Dale, Sigrid Lystad, a...ute for Cancer Research, The,Norwegian Radium Ho...ion , Temporal temperature gradient ele... upon which denaturing gradient gel electropho...l electrophoresis (CDGE) are based. TTGE combines ...
..., Udo Reischl and Christian Gerdes, Instit...ity of Regensburg, 93053 Regensburg, Germany , ...nosis of Epstein-Barr virus (EBV) infection is cur...dies to distinct EBV antigens. In the past few ,...erodiagnostic assay systems , have been c...
..., , Introduction , ... year for use as primers , or probes in g...ions has , traditionally been done by sla... methods may require expensive reagents and labor...ired quantitative precision or automation. Capilla...
Other Biology Technology:Comparison of PCR Kleen Spin Columns to Traditional Methods for Purification of PCR Products Prior to Sequencing, Rev A 2Comparison of PCR Kleen Spin Columns to Traditional Methods for Purification of PCR Products Prior to Sequencing, Rev A 3Comparison of PCR Kleen Spin Columns to Traditional Methods for Purification of PCR Products Prior to Sequencing, Rev A 4TTGE on the DCode System 2TTGE on the DCode System 3TTGE on the DCode System 4Preparative SDS-PAGE Electrophoresis of a Recombinant Epstein-Barr Virus Encoded Protein and Its Application in Serodiagnostic Test Systems, Rev C 2Preparative SDS-PAGE Electrophoresis of a Recombinant Epstein-Barr Virus Encoded Protein and Its Application in Serodiagnostic Test Systems, Rev C 3Preparative SDS-PAGE Electrophoresis of a Recombinant Epstein-Barr Virus Encoded Protein and Its Application in Serodiagnostic Test Systems, Rev C 4Preparative SDS-PAGE Electrophoresis of a Recombinant Epstein-Barr Virus Encoded Protein and Its Application in Serodiagnostic Test Systems, Rev C 5Preparative SDS-PAGE Electrophoresis of a Recombinant Epstein-Barr Virus Encoded Protein and Its Application in Serodiagnostic Test Systems, Rev C 6Preparative SDS-PAGE Electrophoresis of a Recombinant Epstein-Barr Virus Encoded Protein and Its Application in Serodiagnostic Test Systems, Rev C 7Preparative SDS-PAGE Electrophoresis of a Recombinant Epstein-Barr Virus Encoded Protein and Its Application in Serodiagnostic Test Systems, Rev C 8Oligonucleotide Purity Analysis by Capillary Electrophoresis 2Oligonucleotide Purity Analysis by Capillary Electrophoresis 3
(Date:7/24/2008)...am led by Massachusetts General Hospital (MGH) inv...enomic research and medicine a robust method for ...cular DNA sequences for inactivation or repair. ...archers describe an efficient, publicly available ...s (ZFNs), which can be used to induce specific gen...
(Date:7/24/2008)...dy by researchers from Columbia University,s Mailm...st challenging issues in infant health and prevent...ries. In these settings, HIV-infected mothers had...infants, they should exclusively breast-feed, foll...irth. But according to the study conducted in Lusa...
(Date:7/24/2008)...ine researchers have found a molecular link betwee...olism. The discovery reveals new possibilities for...ted diseases. , Paolo Sassone-Corsi, Distinguish...lleagues have identified that an essential protein...rhythms, works in balance with another protein cal...
(Date:7/24/2008)...2008. A fire is currently burning through a study ...or about 2 years ago. Managers used data and analy...R) study in the planning, analysis, and implementa...e is now active., The Gotchen LSR, lies on the e...covers about 15,000 acres of the Mount Adams Range...
Breaking Biology News(10 mins):Consortium develops new method enabling routine targeted gene modification 2Early cessation of breastfeeding by HIV+ women in poor countries and child survival 2Early cessation of breastfeeding by HIV+ women in poor countries and child survival 3Circadian rhythm-metabolism link discovered 2Landscape study may offer solutions for fire managers 2From beach to backyard caution can reduce firepit burns 22960 1From beach to backyard caution can reduce firepit burns 22960 2New electrostatic based DNA microarray technique could revolutionize medical diagnostics 3821 1New electrostatic based DNA microarray technique could revolutionize medical diagnostics 3821 2New electrostatic based DNA microarray technique could revolutionize medical diagnostics 3821 3New electrostatic based DNA microarray technique could revolutionize medical diagnostics 3821 4Tree killing fungus officially named by scientists 3819 1Tree killing fungus officially named by scientists 3819 2Robbins 26 Myers Issues Corrected Conference Call Information 22958 1
...e caused by arterial blockages related to diabetes...ns ?are occurring at an alarming rate. Yet physici...them may be preventable, according to the Internat...nly disfiguring and life-threatening, but are more...on, which is the reestablishment of blood supply. ...
...SX: NRM) is pleased to announce that Neurobiology ... medical journals in the fields of gerontology and...a publication on the preclinical development of tr...ed?, including efficacy results in a mouse model o...sents a potential new class of therapeutic agent a...
...y Professor of Psychology Dr. Jeffrey Mogil shows ...d but unproven even among higher primates, is also... online June 29 in the journal Science, Professor ...lleagues in the Pain Genetics Lab at McGill Univer...t is, familiar to each other) and able to see one ...
...f Texas M. D. Anderson Cancer Center have signific...a cell begins the process of self-destruction - an...argeted cancer therapies. , , In the June 30 is...hat a natural "brake" exists in a cell to prevent ...eath, and they say that optimal anti-cancer therap...
Other Biology News:Epidemic of unneeded amputations 2Tramiprosate (Alzhemed? preclinical results published in Neurobiology of Aging 2Tramiprosate (Alzhemed? preclinical results published in Neurobiology of Aging 3Researchers find molecular 'brake' to cell death 2Researchers find molecular 'brake' to cell death 3
Mouse monoclonal [4i144] to HLA Class II DQ1 7 ( Abpromise for all tested applications). Antigen: Full length protein (Human): HLA Class 2 Antigen DQ1,7.
ASCIZ
Goat polyclonal to CHMP5 ( Abpromise for all tested applications). Antigen: Synthetic peptide: C-NKDGVLVDEFGLPQ, corresponding to C terminal amino acids 202-215 of Human CHMP5 Entrez GeneID:
Custom Oligo Assay Single Locus 1920 samples from Illumina
Biology Products: